<DOC>
	<DOCNO>NCT00518193</DOCNO>
	<brief_summary>The efficacy chimiotherapy cervix epithelial cancer low even association cisplatine - topotecan . News thérapeutics need goal increase survival quality life patient cervix cancer . Cetuximab show potentialisation efficacy cisplatine irinotecan . Cisplatine topotecan show efficacy cervix cancer . Cetuximab well tolerate . Many clinical trial show faisability association cetuximab cisplatine cancer . Many clinical trial show faisability association cetuximab irinotecan colorectals metastatiques cancer .</brief_summary>
	<brief_title>Phase II Study , Association Cisplatine Topotecan Cetuximab Patients Whith Late Progress Epithelial Cancer Cervix</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>More 18 year old . Epidermoïde carcinoma adenocarcinoma cervix , hystologic prove Patientes late stage progresive desease . One mesurable lesion irradiate zone . Patient already treat radiochimiothérapy platine 6 month free interval . Index status ECOG ( `` Eastern Cooperative Oncology Group `` ) less 2 . Good biologicals hematologicals fonctions : Neutrophiles noless 1,5.109/L . Platelets nolss 100.109/L . Total bilirubin 1,5 time normal superior range . Transaminases mote 3 x Time NSR Creatinine clairance Cockroft ) 50 mL/min . Inform consent sign . Previous cytotoxic traitement exept radiochaemiotherapy pelvis cerebrals metastasis . Other cancer last 5 year exept treat BCC . Dermatologic desease . Crohn desease Hemorragic rectalColitis . Neuropathy . Psychologic disorder . Social trouble . Pregnant woman .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>